Evaluating Pre-Analytical Variables for Saliva Cell-Free DNA Liquid Biopsy
Open Access
- 9 May 2023
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 13 (10) , 1665
Abstract
Liquid biopsy utilizing cell-free DNA (cfDNA) has become an emergent field of study for cancer screening and monitoring. While blood-based liquid biopsy has been investigated extensively, there are advantages to using other body fluids. Using saliva is noninvasive, repeatable, and it may be enriched with cfDNA from certain cancer types. However, the lack of standardization in the pre-analytical phase of saliva-based testing is a concern. In this study, we evaluated pre-analytical variables that impact cfDNA stability in saliva specimens. Using saliva from healthy individuals, we tested different collection devices and preservatives and their effects on saliva cfDNA recovery and stability. Novosanis’s UAS preservative helped stabilize cfDNA at room temperature for up to one week. Our study provides useful information for further improvements in saliva collection devices and preservatives.Keywords
Funding Information
- NIH (R21CA239052)
This publication has 25 references indexed in Scilit:
- Salivary Exosome and Cell-Free DNA for Cancer DetectionMicromachines, 2018
- Integrating liquid biopsies into the management of cancerNature Reviews Clinical Oncology, 2017
- Estimation of cell-free circulating EGFR mutation concentration predicts outcomes in NSCLC patients treated with EGFR-TKIsOncotarget, 2017
- Evaluation and comparison of in vitro degradation kinetics of DNA in serum, urine and saliva: A qualitative studyGene, 2016
- Saliva as a diagnostic tool for oral and systemic diseasesJournal of Oral Biology and Craniofacial Research, 2016
- Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomasScience Translational Medicine, 2015
- Rnapro•SAL: A Device for Rapid and Standardized Collection of Saliva RNA and ProteinsBioTechniques, 2015
- Noninvasive Saliva-based EGFR Gene Mutation Detection in Patients with Lung CancerAmerican Journal of Respiratory and Critical Care Medicine, 2014
- Salivary Biomarkers: Toward Future Clinical and Diagnostic UtilitiesClinical Microbiology Reviews, 2013
- Salivary Transcriptomic Biomarkers for Detection of Resectable Pancreatic CancerGastroenterology, 2010